Literature DB >> 27215249

Hemodialysis safety: Evaluation of clinical practice.

Wafaa Fadili1, Adil Adnouni1, Inass Laouad1.   

Abstract

Hemodialysis (HD) safety has become a clinical priority; therefore, the use of checklists for making the dialysis session safe is now widely adopted. The aim of our study was to assess different shortcomings in the clinical practice of nurses working in different Moroccan dialysis centers and to discuss the interest of using such checklists. This cross-sectional study was performed in 13 chronic HD centers. Clinical practice of nurses was evaluated through checklists used in European outpatient dialysis units. We noted several deficiencies mainly related to the clinical evaluation of dialysis patients and to aspects related to hygiene and protection measures against contamination. Optimal safety of dialysis sessions requires the use of simple and reproducible means that improve clinical skills of the health staff.

Entities:  

Mesh:

Year:  2016        PMID: 27215249     DOI: 10.4103/1319-2442.182398

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  3 in total

1.  The impact of hemodialysis on retinal and choroidal thickness in patients with chronic renal failure.

Authors:  Fariba Shaikhi Shoshtari; Sasan Biranvand; Leila Rezaei; Nader Salari; Nasrin Aghaei
Journal:  Int Ophthalmol       Date:  2021-03-19       Impact factor: 2.031

2.  Proactive Risk Assessment Through Failure Mode and Effect Analysis (FMEA) for Haemodialysis Facilities: A Pilot Project.

Authors:  Raffaele La Russa; Valentina Fazio; Michela Ferrara; Nicola Di Fazio; Rocco Valerio Viola; Gianluca Piras; Giuseppe Ciano; Fausta Micheletta; Paola Frati
Journal:  Front Public Health       Date:  2022-03-24

3.  Effectiveness of Comprehensive Nursing in Hemodialysis of Patients with Chronic Renal Failure and the Impact on Their Quality of Life.

Authors:  Quan Wen; Shuang Yao; Bingnan Yao
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-05       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.